Diversified Growth Company - Medtech DPM CHF H/  LU2304351898  /

Fonds
NAV03.07.2024 Diff.-0,1000 Ertragstyp Ausrichtung Fondsgesellschaft
73,2500CHF -0,14% thesaurierend Aktien weltweit NS Partners 

Investmentstrategie

The objective is to achieve a better performance in a global equity market than the MSCI World Health Care Equipment and Supplies (USD) index by investing mainly in shares, certificates of shares and equity-like transferable securities that fall into the investment universe of the medical technology industry globally. The Sub-Fund will have a diversified portfolio exposed to global equity markets (Europe, North America, Asia and emerging markets). The Sub-Fund promotes social and environmental characteristics by investing at least 85% of its net assets in shares, certificates of shares and equity-like transferable securities with exposure to global equity markets that exhibit strong ESG credentials, with a specific focus on CO2 emissions.
 

Investmentziel

The objective is to achieve a better performance in a global equity market than the MSCI World Health Care Equipment and Supplies (USD) index by investing mainly in shares, certificates of shares and equity-like transferable securities that fall into the investment universe of the medical technology industry globally.
 

Stammdaten

Ertragstyp: thesaurierend
Fondskategorie: Aktien
Region: weltweit
Branche: Branche Gesundheit/Pharma
Benchmark: MSCI World Health Care Equipment and Supplies (USD) index
Geschäftsjahresbeginn: 01.01
Letzte Ausschüttung: -
Depotbank: UBS Europe SE, Luxembourg Branch
Ursprungsland: Luxemburg
Vertriebszulassung: Schweiz, Niederlande, Frankreich, Belgien, Italien, Spanien, Luxemburg
Fondsmanager: NS Partners SA
Fondsvolumen: 29,72 Mio.  USD
KESt-Meldefonds: -
Auflagedatum: 11.02.2022
Investmentfokus: -

Konditionen

Ausgabeaufschlag: 3,00%
Max. Verwaltungsgebühr: 1,50%
Mindestveranlagung: - CHF
Weitere Gebühren: -
Tilgungsgebühr: 0,00%
Laufende Kosten (08.02.2019): 1,17%
Wesentliche Anlegerinformation: Download (Druckversion)
 

Fondsgesellschaft

KAG: NS Partners
Adresse: 11, Boulevard de la Foire, 1528, Luxembourg
Land: Luxemburg
Internet: www.nspgroup.com/
 

Veranlagungen

Aktien
 
100,00%

Länder

USA
 
77,50%
Schweiz
 
10,10%
Dänemark
 
5,10%
Deutschland
 
4,40%
Frankreich
 
2,40%
Sonstige
 
0,50%

Branchen

Gesundheitswesen
 
100,00%